Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma

Detalles Bibliográficos
Autores principales: Ratner, Lee, Ramos, JC, Noy, Ariela, Barta, Stefan, Parikh, Samir, Phillips, Adrienne, Ambinder, Richard, Rauch, Dan, Harding, John, Baydoun, Hicham, Cheng, Xiaogang, Caruso, Breanna, Jacobson, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578736/
http://dx.doi.org/10.1186/1742-4690-12-S1-P21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578736/
http://dx.doi.org/10.1186/1742-4690-12-S1-P21

Ejemplares similares